Detalhe da pesquisa
1.
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.
J Neurooncol
; 168(2): 317-332, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630384
2.
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells.
J Neurooncol
; 164(3): 617-632, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37783879
3.
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol
; 163(1): 143-158, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183219
4.
Targeting protein folding in N-Myc-driven medulloblastoma.
Mol Oncol
; 17(3): 387-389, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36786675
5.
BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.
Neuro Oncol
; 25(4): 735-747, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977048
6.
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.
Neuro Oncol
; 23(2): 226-239, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822486
7.
BET-bromodomain inhibitors modulate epigenetic patterns at the diacylglycerol kinase alpha enhancer associated with radiation-induced fibrosis.
Radiother Oncol
; 125(1): 168-174, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28916223